Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'III HYPERLIPOPROTEINEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 173 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shek, A; Ferrill, MJ
      Statin-fibrate combination therapy

      ANNALS OF PHARMACOTHERAPY
    2. Hoffmann, MM; Scharnagl, H; Panagiotou, E; Banghard, WT; Wieland, H; Marz, W
      Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomenulopathy

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    3. Takahashi, K; Hikita, M; Taira, K; Kobayashi, J; Bujo, H; Saito, Y
      Clinical characterization of a case with familial hypobetalipoproteinemia caused by Apo B-76, a new truncation of apolipoprotein B, combined with ApoE2/E2 phenotype

      INTERNAL MEDICINE
    4. Sakatsume, M; Kadomura, M; Sakata, I; Imai, N; Kondo, D; Osawa, Y; Shimada, H; Ueno, M; Miida, T; Nishi, S; Arakawa, M; Gejyo, F
      Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity

      KIDNEY INTERNATIONAL
    5. Moghadasian, MH; Nguyen, LB; Shefer, S; Salen, G; Batta, AK; Frohlich, JJ
      Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: Effects of apolipoprotein E deficiency and probucol or phytosterol treatment

      METABOLISM-CLINICAL AND EXPERIMENTAL
    6. Lund-Katz, S; Wehrli, S; Zaiou, M; Newhouse, Y; Weisgraber, KH; Phillips, MC
      Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE

      JOURNAL OF LIPID RESEARCH
    7. Hockey, KJ; Anderson, RA; Cook, VR; Hantgan, RR; Weinberg, RB
      Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance

      JOURNAL OF LIPID RESEARCH
    8. Libeu, CP; Lund-Katz, S; Phillips, MC; Wehrli, S; Hernaiz, MJ; Capila, I; Linhardt, RJ; Raffai, RL; Newhouse, YM; Zhou, FY; Weisgraber, KH
      New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Kypreos, KE; van Dijk, KW; van der Zee, A; Havekes, LM; Zannis, VI
      Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo - Carboxyl-terminal region 203-299 promotes hepatic verylow density lipoprotein-triglyceride secretion

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Hoffmann, MM; Scharnagl, H; Koster, W; Winkler, K; Wieland, H; Marz, W
      Apolipoprotein E1 Baden (Arg(180)-> Cys) - A new apolipoprotein E variant associated with hypertriglyceridemia

      CLINICA CHIMICA ACTA
    11. Yoshida, H; Hasty, AH; Major, AS; Ishiguro, H; Su, YR; Gleaves, LA; Babaev, VR; Linton, MF; Fazio, S
      Isoform-specific effects of apolipoprotein E on atherogenesis - Gene transduction studies in mice

      CIRCULATION
    12. Dong, J; Peters-Libeu, CA; Weisgraber, KH; Segelke, BW; Rupp, B; Capila, I; Hernaiz, MJ; LeBrun, LA; Linhardt, RJ
      Interaction of the N-terminal domain of apolipoprotein E4 with heparin

      BIOCHEMISTRY
    13. Kypreos, KE; Morani, P; van Dijk, KW; Havekes, LM; Zannis, VI
      The amino-terminal 1-185 domain of ApoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for inductionof hyperlipidemia in normal and ApoE-deficient mice

      BIOCHEMISTRY
    14. Ginsberg, HN; Illingworth, DR
      Postprandial dyslipidemia: An atherogenic disorder common in patients withdiabetes mellitus

      AMERICAN JOURNAL OF CARDIOLOGY
    15. Schaefer, EJ; Audelin, MC; McNamara, JR; Shah, PK; Tayler, T; Daly, JA; Augustin, JL; Seman, LJ; Rubenstein, JJ
      Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease

      AMERICAN JOURNAL OF CARDIOLOGY
    16. de Beer, F; van Dijk, KW; Jong, MC; van Vark, LC; van der Zee, A; Hofker, MH; Fallaux, FJ; Hoeben, RC; Smelt, AHM; Havekes, LM
      Apolipoprotein E2 (Lys146 -> Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low densitylipoproteins-triglycerides

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    17. Marathe, S; Choi, Y; Leventhal, AR; Tabas, I
      Sphingomyelinase converts lipoproteins from apolipoprotein E knockout miceinto potent inducers of macrophage foam cell formation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    18. Van Eck, M; Herijgers, N; Van Dijk, KW; Havekes, LM; Hofker, MH; Groot, PHE; Van Berkel, TJC
      Effect of macrophage-derived mouse apoE, human apoE3-Leiden, and human apoE2 (Arg158 -> Cys) on cholesterol levels and atherosclerosis in apoE-deficient mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    19. Fazio, S; Linton, MF; Swift, LL
      The cell biology and physiologic relevance of apoE recycling

      TRENDS IN CARDIOVASCULAR MEDICINE
    20. Athanasopulos, T; Owen, JS; Hassall, DG; Dunckley, MG; Drew, J; Goodman, J; Tagalakis, AD; Riddell, DR; Dickson, G
      Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice

      HUMAN MOLECULAR GENETICS
    21. Langer, C; Huang, YD; Cullen, P; Wiesenhutter, B; Mahley, RW; Assmann, G; von Eckardstein, A
      Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages

      JOURNAL OF MOLECULAR MEDICINE-JMM
    22. Hubacek, JA; Pitha, J; Stavek, P; Schmitz, G; Poledne, R
      Variable expression of hypercholesterolemia in apolipoprotein E2*Arg136 ->Cys heterozygotes

      PHYSIOLOGICAL RESEARCH
    23. Kokubo, Y; Chowdhury, AH; Date, C; Yokoyama, T; Sobue, H; Tanaka, H
      Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population

      STROKE
    24. Wiebe, C; Holzem, G; Wielckens, K; Klingler, KR
      Apolipoprotein E polymorphism: Automated determination of apolipoprotein E2, E3, and E4 isoforms

      LIPIDS
    25. Marcoux, C; Hopkins, PN; Wang, T; Leary, ET; Nakajima, K; Davignon, J; Cohn, JS
      Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state

      JOURNAL OF LIPID RESEARCH
    26. Zaiou, M; Arnold, KS; Newhouse, YM; Innerarity, TL; Weisgraber, KH; Segall, ML; Phillips, MC; Lund-Katz, S
      Apolipoprotein E-low density lipoprotein receptor interaction: influences of basic residue and amphipathic alpha-helix organization in the ligand

      JOURNAL OF LIPID RESEARCH
    27. Batal, R; Tremblay, M; Barrett, PHR; Jacques, H; Fredenrich, A; Mamer, O; Davignon, J; Cohn, JS
      Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

      JOURNAL OF LIPID RESEARCH
    28. Tsukamoto, K; Maugeais, C; Glick, JM; Rader, DJ
      Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice

      JOURNAL OF LIPID RESEARCH
    29. Lund-Katz, S; Zaiou, M; Wehrli, S; Dhanasekaran, P; Baldwin, F; Weisgraber, KH; Phillips, MC
      Effects of lipid interaction on the lysine microenvironments in apolipoprotein E

      JOURNAL OF BIOLOGICAL CHEMISTRY
    30. Morrow, JA; Arnold, KS; Dong, J; Balestra, ME; Innerarity, TL; Weisgraber, KH
      Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    31. Carmena, R; Roy, M; Roederer, G; Minnich, A; Davignon, J
      Coexisting dysbetalipoproteinemia and familial hypercholesterolemia - Clinical and laboratory observations

      ATHEROSCLEROSIS
    32. Hirany, S; O'Byrne, D; Devaraj, S; Jialal, I
      Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease

      CLINICAL CHEMISTRY
    33. Okazaki, M; Usui, S; Tada, N; Nakano, T; Nakajima, K
      Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC

      CLINICA CHIMICA ACTA
    34. Dallongeville, J
      Apolipoprotein E mutations, type V hyperlipoproteinaemia and diet

      BRITISH JOURNAL OF NUTRITION
    35. Vialettes, B; Reynier, P; Atlan-Gepner, C; Mekki, N; Lesluyes-Mazzochi, L; Luc, G; Lairon, D; Malthiery, Y
      Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136 -> Ser)

      BRITISH JOURNAL OF NUTRITION
    36. Chew, STH; Newman, MF; White, WD; Conlon, PJ; Saunders, AM; Strittmatter, WJ; Landolfo, K; Grocott, HP; Stafford-Smith, M
      Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients

      ANESTHESIOLOGY
    37. Tsukamoto, K; Tangirala, R; Chun, SH; Pure, E; Rader, DJ
      Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    38. Orth, M; Weng, W; Funke, H; Steinmetz, A; Assmann, G; Nauck, M; Dierkes, J; Ambrosch, A; Weisgraber, KH; Mahley, RW; Wieland, H; Luley, C
      Effects of a frequent apolipoprotein E isoform, ApoE4(Freiburg) (Leu28 -> Pro), on lipoproteins and the prevalence of coronary artery disease in whites

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    39. de Beer, F; Hendriks, WL; van Vark, LC; Kamerling, SWA; van Dijk, KW; Hofker, MH; Smelt, AHM; Havekes, LM
      Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoproteinlipase, whereas ApoE only modulates binding affinity

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    40. van Dijk, KW; van Vlijmen, BJM; de Winther, MPJ; van't Hof, B; van der Zee, A; van der Boom, H; Havekes, LM; Hofker, MH
      Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    41. Huang, YD; Ji, ZS; Brecht, WJ; Rall, SC; Taylor, JM; Mahley, RW
      Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    42. Sijbrands, EJ; Hoffer, MJV; Meinders, AE; Havekes, LM; Frants, RR; Smelt, AHM; De Knijff, P
      Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    43. Mahley, RW; Huang, YD
      Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

      CURRENT OPINION IN LIPIDOLOGY
    44. Matsushima, Y; Hayashi, S; Tachibana, H
      Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency

      MAMMALIAN GENOME
    45. Cole, GM; Beech, W; Frautschy, SA; Sigel, J; Glasgow, C; Ard, MD
      Lipoprotein effects on A beta accumulation and degradation by microglia invitro

      JOURNAL OF NEUROSCIENCE RESEARCH
    46. Saito, T; Oikawa, S; Sato, H; Sato, T; Ito, S; Sasaki, J
      Lipoprotein glomerulopathy: Significance of lipoprotein and ultrastructural features

      KIDNEY INTERNATIONAL
    47. Crook, MA; Mukherjee, A; Marshall, K
      Unusual presentations to a lipid clinic

      POSTGRADUATE MEDICAL JOURNAL
    48. Saito, T; Oikawa, S; Sato, H; Sasaki, J
      Lipoprotein glomerulopathy: Renal lipidosis induced by novel apolipoprotein E variants

      NEPHRON
    49. Hasty, AH; Linton, MF; Swift, LL; Fazio, S
      Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance

      JOURNAL OF LIPID RESEARCH
    50. Medh, JD; Bowen, SL; Fry, GL; Ruben, S; Hill, J; Wong, H; Chappell, DA
      Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro

      JOURNAL OF LIPID RESEARCH
    51. Mahley, RW; Ji, ZS
      Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

      JOURNAL OF LIPID RESEARCH
    52. Knouff, C; Hinsdale, ME; Mezdour, H; Altenburg, MK; Watanabe, M; Quarfordt, SH; Sullivan, PM; Maeda, N
      Apo E structure determines VLDL clearance and atherosclerosis risk in mice

      JOURNAL OF CLINICAL INVESTIGATION
    53. Weintraub, M; Grosskopf, I; Trostanesky, Y; Charach, G; Rubinstein, A; Stern, N
      Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    54. Mann, WA; Meyer, N; Berg, D; Greten, H; Beisiegel, U
      Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors

      ATHEROSCLEROSIS
    55. Otto, C; Schwandt, P
      When statins are not enough to lower lipid levels - Benefits and risks of lipid-lowering combination therapy, especially the combination statin and fibrate

      INTERNIST
    56. QIAN XB; BALESTRA ME; YAMANAKA S; BOREN J; LEE I; INNERARITY TL
      LOW EXPRESSION OF THE APOLIPOPROTEIN-B MESSENGER-RNA-EDITING TRANSGENE IN MICE REDUCES LDL LEVELS BUT DOES NOT CAUSE LIVER DYSPLASIA OR TUMORS

      Arteriosclerosis, thrombosis, and vascular biology
    57. FEUSSNER G; FEUSSNER V; HOFFMANN MM; LOHRMANN J; WIELAND H; MARZ W
      MOLECULAR-BASIS OF TYPE-III HYPERLIPOPROTEINEMIA IN GERMANY

      Human mutation
    58. WILLIAMS KJ; TABAS I
      THE RESPONSE-TO-RETENTION HYPOTHESIS OF ATHEROGENESIS REINFORCED

      Current opinion in lipidology
    59. CABEZAS MC; DEBRUIN TWA; WESTERVELD HE; MEIJER E; ERKELENS DW
      DELAYED CHYLOMICRON REMNANT CLEARANCE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

      Journal of internal medicine
    60. BRUMMER D; EVANS D; BERG D; GRETEN H; BEISIEGEL U; MANN WA
      EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN PATIENTS HOMOZYGOUS FOR APOLIPOPROTEIN E-2 IS MODULATED BY LIPOPROTEIN-LIPASE AND POSTPRANDIAL HYPERINSULINEMIA

      Journal of molecular medicine
    61. CHANDRA V; PANDAV R
      GENE-ENVIRONMENT INTERACTION IN ALZHEIMERS-DISEASE - A POTENTIAL ROLEFOR CHOLESTEROL

      Neuroepidemiology
    62. ZHU YH; BELLOSTA S; LANGER C; BERNINI F; PITAS RE; MAHLEY RW; ASSMANN G; VONECKARDSTEIN A
      LOW-DOSE EXPRESSION OF A HUMAN APOLIPOPROTEIN-E TRANSGENE IN MACROPHAGES RESTORES CHOLESTEROL EFFLUX CAPACITY OF APOLIPOPROTEIN E-DEFICIENTMOUSE PLASMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    63. IKEUCHI R; SAKUMA N; HAYANO J; FUJINAMI T
      FRACTIONAL REMOVAL RATE OF FAT EMULSION (K-2) REMAINS TO BE LOW IN APOE3 3 PHENOTYPE SUBJECTS WITH SERUM TRIGLYCERIDE LEVEL ABOVE 180MG/DL/

      Life sciences
    64. ZSIGMOND E; FUKE Y; LI L; KOBAYASHI K; CHAN L
      RESISTANCE OF CHYLOMICRON AND VLDL REMNANTS TO POSTHEPARIN LIPOLYSIS IN APOE-DEFICIENT MICE - THE ROLE OF APOE IN LIPOPROTEIN LIPASE-MEDIATED LIPOLYSIS IN-VIVO AND IN-VITRO

      Journal of lipid research
    65. DONG LM; INNERARITY TL; ARNOLD KS; NEWHOUSE YM; WEISGRABER KH
      THE CARBOXYL-TERMINUS IN APOLIPOPROTEIN E2 AND THE 7 AMINO-ACID REPEAT IN APOLIPOPROTEIN E-LEIDEN - ROLE IN RECEPTOR-BINDING ACTIVITY

      Journal of lipid research
    66. HUANG YD; LIU XQ; RALL SC; TAYLOR JM; VONECKARDSTEIN A; ASSMANN G; MAHLEY RW
      OVEREXPRESSION AND ACCUMULATION OF APOLIPOPROTEIN-E AS A CAUSE OF HYPERTRIGLYCERIDEMIA

      The Journal of biological chemistry
    67. HUANG YD; LIU XQ; RALL SC; MAHLEY RW
      APOLIPOPROTEIN E2 REDUCES THE LOW-DENSITY-LIPOPROTEIN LEVEL IN TRANSGENIC MICE BY IMPAIRING LIPOPROTEIN LIPASE-MEDIATED LIPOLYSIS OF TRIGLYCERIDE-RICH LIPOPROTEINS

      The Journal of biological chemistry
    68. JI ZS; PITAS RE; MAHLEY RW
      DIFFERENTIAL CELLULAR ACCUMULATION RETENTION OF APOLIPOPROTEIN-E MEDIATED BY CELL-SURFACE HEPARAN-SULFATE PROTEOGLYCANS - APOLIPOPROTEINS E3 AND E2 GREATER-THAN E4

      The Journal of biological chemistry
    69. OKUBO M; AOYAMA Y; HARADA K; FUKAWA M; TSUKADA T; MOKUNO H; YAMADA N; MURASE T
      A NOVEL APOLIPOPROTEIN E2 VARIANT, E2(TORANOMON)(Q187E), IDENTIFIED IN A TYPE-III HYPERLIPOPROTEINEMIA PATIENT WITH CORONARY ATHEROSCLEROSIS

      Atherosclerosis (Amsterdam)
    70. DEMACKER PNM; BREDIE SJH; VOGELAAR JM; HECTORS MPC; VANHEIJST P; STUYT PMJ; STALENHOEF AFH
      BETA-VLDL ACCUMULATION IN FAMILIAL DYSBETALIPOPROTEINEMIA IS ASSOCIATED WITH INCREASED EXCHANGE OR DIFFUSION OF CHYLOMICRON LIPIDS TO APO B-100 CONTAINING TRIGLYCERIDE-RICH LIPOPROTEINS

      Atherosclerosis (Amsterdam)
    71. BIOLETTO S; FONTANA P; DARIOLI R; JAMES RW
      APOLIPOPROTEIN-E POLYMORPHISM AND THE DISTRIBUTION PROFILE OF VERY-LOW-DENSITY LIPOPROTEINS - AN INFLUENCE OF THE E4 ALLELE ON LARGE (SF-GREATER-THAN-60) PARTICLES

      Atherosclerosis
    72. DEMAN FHAF; DEBEER F; VANDERLAARSE A; SMELT AHM; LEUVEN JAG; HAVEKES LM
      EFFECT OF APOLIPOPROTEIN-E VARIANTS ON LIPOLYSIS OF VERY-LOW-DENSITY LIPOPROTEINS BY HEPARAN-SULFATE PROTEOGLYCAN-BOUND LIPOPROTEIN-LIPASE

      Atherosclerosis
    73. Chung, BH; Segrest, JP; Franklin, F
      In vitro production of beta-very low density lipoproteins and small, denselow density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin : cholester acyltransferase, cholesterylester transferproteins and lipoprotein lipase

      ATHEROSCLEROSIS
    74. DOBMEYER JM; REXIN M; DOBMEYER TS; KLEIN SA; ROSSOL R; FEUSSNER G
      QUANTITATION OF APOLIPOPROTEIN-EPSILON GENE-EXPRESSION BY COMPETITIVEPOLYMERASE-CHAIN-REACTION IN A PATIENT WITH FAMILIAL APOLIPOPROTEIN-EDEFICIENCY

      Clinica chimica acta
    75. Tsunoda, K; Yamamoto, Y; Akiya, Y; Sato, K; Rajbhandary, HB; Son, HV; Loc, CB
      Apolipoprotein E polymorphism in sheep

      BIOCHEMICAL GENETICS
    76. ADDYA K; WANG YL; LEONARD DGB
      OPTIMIZATION OF APOLIPOPROTEIN-E GENOTYPING

      Molecular diagnosis
    77. DEVILLIERS WJS; VANDERWESTHUYZEN DR; COETZEE GA; HENDERSON HE; MARAIS AD
      THE APOLIPOPROTEIN E2 (ARG145CYS) MUTATION CAUSES AUTOSOMAL-DOMINANT TYPE-III HYPERLIPOPROTEINEMIA WITH INCOMPLETE PENETRANCE

      Arteriosclerosis, thrombosis, and vascular biology
    78. HENDRIKS WL; VANDERSMANDEBEER F; VANVLIJMEN BJM; VANVARK LC; HOFKER MH; HAVEKES LM
      UPTAKE BY J774 MACROPHAGES OF VERY-LOW-DENSITY LIPOPROTEINS ISOLATED FROM APOE-DEFICIENT MICE IS MEDIATED BY A DISTINCT RECEPTOR AND STIMULATED BY LIPOPROTEIN-LIPASE

      Arteriosclerosis, thrombosis, and vascular biology
    79. COHN JS; GIROUX LM; FORTIN LJ; DAVIGNON J
      PREVALENCE OF DOUBLE PRE-BETA LIPOPROTEINEMIA IN HYPERLIPIDEMIC PATIENTS IS INFLUENCED BY GENDER, MENOPAUSAL STATUS, AND APOE PHENOTYPE

      Arteriosclerosis, thrombosis, and vascular biology
    80. HUANG Y; RALL SC; MAHLEY RW
      GENETIC-FACTORS PRECIPITATING TYPE-III HYPERLIPOPROTEINEMIA IN HYPOLIPIDEMIC TRANSGENIC MICE EXPRESSING HUMAN APOLIPOPROTEIN E2

      Arteriosclerosis, thrombosis, and vascular biology
    81. VANECK M; HERIJGERS N; YATES J; PEARCE NJ; HOOGERBRUGGE PM; GROOT PHE; VANBERKEL TJC
      BONE-MARROW TRANSPLANTATION IN APOLIPOPROTEIN-E DEFICIENT MICE - EFFECT OF APOE GENE DOSAGE ON SERUM-LIPID CONCENTRATIONS, (BETA)VLDL CATABOLISM, AND ATHEROSCLEROSIS

      Arteriosclerosis, thrombosis, and vascular biology
    82. OIKAWA S; MATSUNAGA A; SAITO T; SATO H; SEKI T; HOSHI K; HAYASAKA K; KOTAKE H; MIDORIKAWA H; SEKIKAWA A; HARA S; ABE K; TOYOTA T; JINGAMI H; NAKAMURA H; SASAKI J
      APOLIPOPROTEIN-E SENDAI (ARGININE 145-]PROLINE) - A NEW VARIANT ASSOCIATED WITH LIPOPROTEIN GLOMERULOPATHY

      Journal of the American Society of Nephrology
    83. TAKEICHI S; NAKAJIMA Y; OSAWA M; YUKAWA N; SAITO T; SETO Y; NAKANO T; ADACHI M; JITSUKATA K; HORIUCHI K; WANG T; NAKAJIMA K
      THE POSSIBLE ROLE OF REMNANT-LIKE PARTICLES AS A RISK FACTOR FOR SUDDEN CARDIAC DEATH

      International journal of legal medicine
    84. NOZAKI S; ITO Y; NAKAGAWA T; YAMASHITA S; SASAKI J; MATSUZAWA Y
      AUTOIMMUNE HYPERLIPIDEMIA WITH INHIBITORY MONOCLONAL-ANTIBODIES AGAINST LOW-DENSITY-LIPOPROTEIN BINDING TO FIBROBLASTS IN A CASE WITH MULTIPLE-MYELOMA

      Internal medicine
    85. IKEUCHI R; SAKUMA N; HASEGAWA Y; HIBINO T; YONEYAMA A; TAMAI N; SASAI K; YOSHIMATA T
      SIGNIFICANT CORRELATION BETWEEN FRACTIONAL REMOVAL RATE (K-2) OF FAT EMULSION AND SERUM TRIGLYCERIDE OR APOLIPOPROTEIN-A-I IN SUBJECTS WITHAPOE PHENOTYPE-3 3/

      Journal of clinical biochemistry and nutrition
    86. FERNANDEZMIRANDA C; CANCELAS P; DELACALLE A; GOMEZ R; MORENO E; GOMEZGERIQUE J; DELPALACIO A
      CHANGES IN PHENOTYPES OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN(A) IN LIVER-TRANSPLANT RECIPIENTS

      Clinical transplantation
    87. FEUSSNER G; PIESCH S; DOBMEYER J; FISCHER C
      GENETICS OF TYPE-III HYPERLIPOPROTEINEMIA

      Genetic epidemiology
    88. PAN XM; STAPRANS I; HARDMAN DA; RAPP JH
      EXPOSURE TO CIGARETTE-SMOKE DELAYS THE PLASMA-CLEARANCE OF CHYLOMICRONS AND CHYLOMICRON REMNANTS IN RATS

      American journal of physiology: Gastrointestinal and liver physiology
    89. RICHARD P; BEUCLER I; DEZULUETA MP; BITEAU N; DEGENNES JL; IRON A
      COMPOUND HETEROZYGOTE FOR BOTH RARE APOLIPOPROTEIN E1(GLY(127)-]ASP, ARG(158)-]CYS) AND E3(CYS(112)-]ARG, ARG(251)-]GLY) ALLELES IN A MULTIGENERATION PEDIGREE WITH HYPERLIPOPROTEINEMIA

      Clinical science
    90. SAITO T
      ABNORMAL LIPID-METABOLISM AND RENAL DISORDERS

      Tohoku Journal of Experimental Medicine
    91. ODA H; YORIOKA N; OKUSHIN S; NISHIDA Y; KUSHIHATA S; ITO T; YAMAKIDO M
      REMNANT-LIKE PARTICLE CHOLESTEROL MAY INDICATE ATHEROGENIC RISK IN PATIENTS ON CHRONIC-HEMODIALYSIS

      Nephron
    92. TSUKAMOTO K; SMITH P; GLICK JM; RADER DJ
      LIVER-DIRECTED GENE-TRANSFER AND PROLONGED EXPRESSION OF 3 MAJOR HUMAN APOE ISOFORMS IN APOE-DEFICIENT MICE

      The Journal of clinical investigation
    93. ANAMI Y; KOBORI S; SAKAI M; KASHO M; NISHIKAWA T; YANO T; MATSUDA H; MATSUMURA T; TAKEMURA T; SHICHIRI M
      HUMAN BETA-MIGRATING VERY-LOW-DENSITY LIPOPROTEIN INDUCES FOAM CELL-FORMATION IN HUMAN MESANGIAL CELLS

      Atherosclerosis
    94. YANAGI K; YAMASHITA S; KIHARA S; NAKAMURA T; NOZAKI S; NAGAI Y; FUNAHASHI T; KAMEDATAKEMURA K; UEYAMA Y; JIAO S; KUBO M; TOKUNAGA K; MATSUZAWA Y
      CHARACTERISTICS OF CORONARY-ARTERY DISEASE AND LIPOPROTEIN ABNORMALITIES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ASSOCIATED WITH DIABETES-MELLITUS OR IMPAIRED GLUCOSE-TOLERANCE

      Atherosclerosis
    95. YANAGI K; YAMASHITA S; HIRAOKA H; ISHIGAMI M; KIHARA S; HIRANO K; SAKAI N; NOZAKI S; FUNAHASHI T; KAMEDATAKEMURA K; KUBO M; TOKUNAGA K; MATSUZAWA Y
      INCREASED SERUM REMNANT LIPOPROTEINS IN PATIENTS WITH APOLIPOPROTEIN E7 (APO E-SUITA)

      Atherosclerosis
    96. FAZIO S; LINTON MF
      MURINE BONE-MARROW TRANSPLANTATION AS A NOVEL-APPROACH TO STUDYING THE ROLE OF MACROPHAGES IN LIPOPROTEIN METABOLISM AND ATHEROGENESIS

      Trends in cardiovascular medicine
    97. BALSON KR; NIALL JF; BEST JD
      GLOMERULAR LIPID DEPOSITION AND PROTEINURIA IN A PATIENT WITH FAMILIAL DYSBETALIPOPROTEINEMIA

      Journal of internal medicine
    98. CONTOIS JH; ANAMANI DE; TSONGALIS GJ
      THE UNDERLYING MOLECULAR MECHANISM OF APOLIPOPROTEIN-E POLYMORPHISM -RELATIONSHIPS TO LIPID DISORDERS, CARDIOVASCULAR-DISEASE, AND ALZHEIMERS-DISEASE

      Clinics in laboratory medicine
    99. FEUSSNER G; DOBMEYER J; NISSEN H; HANSEN TS
      UNUSUAL XANTHOMAS IN A YOUNG PATIENT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE-III HYPERLIPOPROTEINEMIA

      American journal of medical genetics
    100. STAMAND J; MOORJANI S; LUPIEN PJ; PRUDHOMME D; DESPRES JP
      RELATION OF PLASMA TRIGLYCERIDE, APOLIPOPROTEIN-B, AND HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL TO POSTHEPARIN LIPOPROTEIN-LIPASE ACTIVITY IS DEPENDENT ON APOLIPOPROTEIN-E POLYMORPHISM

      Metabolism, clinical and experimental


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 06:36:00